Nicholas W. Baxter - 01 Sep 2021 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Nicholas Baxter/
Issuer symbol
LEXX
Transactions as of
01 Sep 2021
Net transactions value
$0
Form type
4
Filing time
02 Sep 2021, 13:32:02 UTC
Previous filing
30 Aug 2021
Next filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 11,000 01 Sep 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +1,900 +29% $0.000000 8,400 01 Sep 2021 Common Shares 1,900 $6.23 Direct
holding LEXX Stock Options 1,500 01 Sep 2021 Common Shares 1,500 $5.31 Direct
holding LEXX Stock Options 6,500 01 Sep 2021 Common Shares 5,000 $7.08 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.